AAAAAA

   
Results: 1-25 |
Results: 25
B-CELL COMPARTMENTS IN MULTIPLE-MYELOMA - FLOW CYTOMETRIC ANALYSIS OFTHEIR LABELING INDEXES AND BCL-2 PROTEIN EXPRESSION
Authors: TRIMOREAU F GACHARD N JACCARD A TONI FB BORDESSOULE D PRALORAN V
Citation: F. Trimoreau et al., B-CELL COMPARTMENTS IN MULTIPLE-MYELOMA - FLOW CYTOMETRIC ANALYSIS OFTHEIR LABELING INDEXES AND BCL-2 PROTEIN EXPRESSION, HEM CELL TH, 40(1), 1998, pp. 11-16
EFFECTS OF LIPID MEDIATORS ON THE SYNTHESIS OF LEUKEMIA INHIBITORY FACTOR AND INTERLEUKIN-6 BY HUMAN BONE-MARROW STROMAL CELLS
Authors: DENIZOT Y TRIMOREAU F PRALORAN V
Citation: Y. Denizot et al., EFFECTS OF LIPID MEDIATORS ON THE SYNTHESIS OF LEUKEMIA INHIBITORY FACTOR AND INTERLEUKIN-6 BY HUMAN BONE-MARROW STROMAL CELLS, Cytokine (Philadelphia, Pa. Print), 10(10), 1998, pp. 781-785
EFFECTS OF LIPOXYGENASE METABOLITES OF ARACHIDONIC-ACID ON THE GROWTHOF HUMAN MONONUCLEAR MARROW-CELLS AND MARROW STROMAL CELL-CULTURES
Authors: DESPLAT V DUPUIS F TRIMOREAU F DULERY C PRALORAN V DENIZOT Y
Citation: V. Desplat et al., EFFECTS OF LIPOXYGENASE METABOLITES OF ARACHIDONIC-ACID ON THE GROWTHOF HUMAN MONONUCLEAR MARROW-CELLS AND MARROW STROMAL CELL-CULTURES, Mediators of inflammation, 7(1), 1998, pp. 31-33
PANCYTOPENIA AND PULMONARY TUBERCULOSIS - THE SIGNIFICANCE OF A HEMOPHAGOCYTIC SYNDROME
Authors: FRANCOIS B CLAVEL M TRIMOREAU F DESACHY A SLAOUTI P GASTINNE H
Citation: B. Francois et al., PANCYTOPENIA AND PULMONARY TUBERCULOSIS - THE SIGNIFICANCE OF A HEMOPHAGOCYTIC SYNDROME, Revue des maladies respiratoires, 15(5), 1998, pp. 668-670
ARACHIDONIC-ACID AND HUMAN BONE-MARROW STROMAL CELLS
Authors: DENIZOT Y DULERY C TRIMOREAU F DESPLAT V PRALORAN V
Citation: Y. Denizot et al., ARACHIDONIC-ACID AND HUMAN BONE-MARROW STROMAL CELLS, Biochimica et biophysica acta. Molecular cell research, 1402(2), 1998, pp. 209-215
HUMAN-HERPESVIRUS-8 AND RELATIVES OF PATIENTS WITH PLASMACYTIC DISEASES
Authors: JACCARD A TOUATI M SOL C BORDESSOULE D COUTY JP ROGEZ S TRIMOREAU F
Citation: A. Jaccard et al., HUMAN-HERPESVIRUS-8 AND RELATIVES OF PATIENTS WITH PLASMACYTIC DISEASES, Blood, 92(9), 1998, pp. 3488-3488
IS TREATMENT WITH HYDROXYUREA LEUKEMOGENIC IN PATIENTS WITH ESSENTIALTHROMBOCYTHEMIA - AN ANALYSIS OF 3 NEW CASES OF LEUKEMIC TRANSFORMATION AND REVIEW OF THE LITERATURE
Authors: LIOZON E BRIGAUDEAU C TRIMOREAU F DESANGLES F FERMEAUX V PRALORAN V BORDESSOULE D
Citation: E. Liozon et al., IS TREATMENT WITH HYDROXYUREA LEUKEMOGENIC IN PATIENTS WITH ESSENTIALTHROMBOCYTHEMIA - AN ANALYSIS OF 3 NEW CASES OF LEUKEMIC TRANSFORMATION AND REVIEW OF THE LITERATURE, HEM CELL TH, 39(1), 1997, pp. 11-18
LEUKEMIA INHIBITORY FACTOR CONCENTRATIONS IN THE BONE-MARROW PLASMA OF HEALTHY-SUBJECTS AND PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: LORGEOT V TRIMOREAU F GACHARD N PRALORAN V DENIZOT Y
Citation: V. Lorgeot et al., LEUKEMIA INHIBITORY FACTOR CONCENTRATIONS IN THE BONE-MARROW PLASMA OF HEALTHY-SUBJECTS AND PATIENTS WITH HEMATOLOGIC MALIGNANCIES, European cytokine network, 8(1), 1997, pp. 57-59
HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS
Authors: MAYNADIE M CAMPOS L MOSKOVTCHENKO P SABIDO O AHO S LENORMAND B CARLI PM GUYOTAT D BENE MC FAURE G CAPIOD JC GARDAIS J FEUILLARD J RAPHAEL M LACOMBE R LECALVEZ G LEGLISE MC DENEYS V MASSON AM BERNIER M MALET AM SALAUN C BOURIN P RAPATEL C TAVERNIER F JOUAULT H LELONG F CHRETIEN P SOLARY E CASASNOVAS RO MAYNADIE M MOSKOVTCHENKO P FAVRE M BENSA JC JACOB MC WALLEF G SARIAUX C TRIMOREAU F PRALORAN V CAMPOS L SABIDO O VASSELON C BRUNET C PONCELET P GUITARD AM TAIB J LAVABREBERTRAND T JUNG G KANDEL G GARAND R PHILIP P SUDAKA I MONPOUX F VANHAEKE D PERROT JY MARIE JP VALENSI F VERGE V HOMBERG JC SCHAISON G BOUMSELL L DOUAY L SAMSON T BRIZARD A DALIPHARD S DRENOU B LEES O LENORMAND B POILANE B FALKENRODT A ALBERT A KUHLEIN E ESTIENNE MH BREMOND JL DEGENNE M LEBARON F REUMAUX G DUTHILLEUL P BENE MC FAURE G BORDIGONI P WITZ F KOLLOPSARDA MN BAYLE C ANTONINI J BOUCHEIX C CHARPENTIER A
Citation: M. Maynadie et al., HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS, Leukemia & lymphoma, 25(1-2), 1997, pp. 135-143
PRESENCE AND METABOLISM OF LYSO-PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW
Authors: DENIZOT Y ROUGIER F DUPUIS F TRIMOREAU F DULERY C LASKAR M PRALORAN V
Citation: Y. Denizot et al., PRESENCE AND METABOLISM OF LYSO-PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW, Journal of lipid mediators and cell signalling, 16(1), 1997, pp. 53-62
PRODUCTION AND METABOLISM OF PLATELET-ACTIVATING-FACTOR BY HUMAN BONE-MARROW CELLS
Authors: DUPUIS F ROUGIER F TRIMOREAU F OSTYN E DULERY C PRALORAN V DENIZOT Y
Citation: F. Dupuis et al., PRODUCTION AND METABOLISM OF PLATELET-ACTIVATING-FACTOR BY HUMAN BONE-MARROW CELLS, Research in immunology, 148(2), 1997, pp. 119-126
NO SEX-RELATED DIFFERENCE IN THE MYELOID ERYTHROID RATIO IN MORPHOLOGICALLY NORMAL BONE-MARROW ASPIRATES/
Authors: TRIMOREAU F VERGER C PRALORAN V DENIZOT Y
Citation: F. Trimoreau et al., NO SEX-RELATED DIFFERENCE IN THE MYELOID ERYTHROID RATIO IN MORPHOLOGICALLY NORMAL BONE-MARROW ASPIRATES/, British Journal of Haematology, 97(3), 1997, pp. 687-687
CYTOGENETIC STUDY OF 30 PATIENTS WITH MULTIPLE-MYELOMA - COMPARISON OF 3 AND 6 DAY BONE-MARROW CULTURES STIMULATED OR NOT WITH CYTOKINES BYUSING A MINIATURIZED KARYOTYPIC METHOD
Authors: BRIGAUDEAU C TRIMOREAU F GACHARD N ROUZIER E JACCARD A BORDESSOULE D PRALORAN V
Citation: C. Brigaudeau et al., CYTOGENETIC STUDY OF 30 PATIENTS WITH MULTIPLE-MYELOMA - COMPARISON OF 3 AND 6 DAY BONE-MARROW CULTURES STIMULATED OR NOT WITH CYTOKINES BYUSING A MINIATURIZED KARYOTYPIC METHOD, British Journal of Haematology, 96(3), 1997, pp. 594-600
THROMBOCYTOPENIA IN THE SEPSIS SYNDROME - ROLE OF HEMOPHAGOCYTOSIS AND MACROPHAGE-COLONY-STIMULATING FACTOR
Authors: FRANCOIS B TRIMOREAU F VIGNON P FIXE P PRALORAN V GASTINNE H
Citation: B. Francois et al., THROMBOCYTOPENIA IN THE SEPSIS SYNDROME - ROLE OF HEMOPHAGOCYTOSIS AND MACROPHAGE-COLONY-STIMULATING FACTOR, The American journal of medicine, 103(2), 1997, pp. 114-120
MACROPHAGE-COLONY-STIMULATING FACTOR LEVELS IN THE PLASMA OF BONE-MARROW ASPIRATE IN SEVERAL HEMATOLOGICAL MALIGNANCIES
Authors: DENIZOT Y FIXE P TRIMOREAU F PRALORAN V
Citation: Y. Denizot et al., MACROPHAGE-COLONY-STIMULATING FACTOR LEVELS IN THE PLASMA OF BONE-MARROW ASPIRATE IN SEVERAL HEMATOLOGICAL MALIGNANCIES, Stem cells, 14(3), 1996, pp. 363-364
PAF AND HEMATOPOIESIS .4. PLATELET-ACTIVATING-FACTOR INCREASES DNA-SYNTHESIS IN HUMAN BONE-MARROW CELLS
Authors: DENIZOT Y DUPUIS F TRIMOREAU F VERGER C ALLEGRAUD A PRALORAN V
Citation: Y. Denizot et al., PAF AND HEMATOPOIESIS .4. PLATELET-ACTIVATING-FACTOR INCREASES DNA-SYNTHESIS IN HUMAN BONE-MARROW CELLS, Journal of lipid mediators and cell signalling, 15(1), 1996, pp. 1-4
DELETION OF CHROMOSOME 20Q ASSOCIATED WITH HYPEREOSINOPHILIC SYNDROME- A REPORT OF 2 CASES
Authors: BRIGAUDEAU C LIOZON E BERNARD P TRIMOREAU F BORDESSOULE D PRALORAN V
Citation: C. Brigaudeau et al., DELETION OF CHROMOSOME 20Q ASSOCIATED WITH HYPEREOSINOPHILIC SYNDROME- A REPORT OF 2 CASES, Cancer genetics and cytogenetics, 87(1), 1996, pp. 82-84
EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: VANHAEKE DR BENE MC GARAND R FAURE GC GARDAIS J LEGLISE MC LECALVEZ G BERNIER M MASSY M GRIVEAU AM BROUTARD P LEBRUN C BONHOMME J CHASSAGNE B DEMEOCQ F RAPATEL C TAVERNIER F JOUAULT H LELONG F CHRETIEN P SOLARY E CASASNOVAS RO MAYNADIE M BENSA JC FAVRE M JACOB MC SARTIAUX C HUART JL DROUET M PRALORAN V TRIMOREAU F CAMPOS L LARESE A PONCELET P BESSONFAURE I BRUNET C LAVABREBERTRAND T TAIB J KANDEL G JUNG G HARROUSSEAU JL PHILIP P MONPOUX F BAUDOUIN F SUDAKA I CALDANI C VANHAEKE D BERNARD A VALENSI F BOURIN P ARBORIO M SCHAISON G BOUMSELL L ADAM M DOUAI L BRIZARD A DALIPHARD S GENETET N FAUCHET R DRENOU B LEES O LENORMAND B VANNIER JP SABIDO O GUYOTAT D VASSELON C FALKENRODT A ALBERT A BREMOND JL GEORGET MT KUHLEIN E LEBARON F DUTHILLEUL P REUMAUX F FAURE G KOLOPPSARDA MN BORDIGONI P WITZ F BAYLE C ANTONINI J CHARPENTIER A
Citation: Dr. Vanhaeke et al., EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia & lymphoma, 20(1-2), 1995, pp. 137-142
PLATELET-ACTIVATING-FACTOR CONCENTRATIONS IN BONE-MARROW OF PATIENTS WITH LYMPHOID AND NONLYMPHOID HEMATOLOGIC MALIGNANCIES
Authors: DENIZOT Y TRIMOREAU F DUPUIS F VERGER C PRALORAN V
Citation: Y. Denizot et al., PLATELET-ACTIVATING-FACTOR CONCENTRATIONS IN BONE-MARROW OF PATIENTS WITH LYMPHOID AND NONLYMPHOID HEMATOLOGIC MALIGNANCIES, Leukemia, 9(11), 1995, pp. 1982-1983
REACTIVE HEMOPHAGOCYTIC SYNDROME - A PROB ABLY UNDERESTIMATED CAUSE OF THROMBOCYTOPENIA IN ICU PATIENTS
Authors: FRANCOIS B TRIMOREAU F VIGNON P VERGER G GASTINNE H
Citation: B. Francois et al., REACTIVE HEMOPHAGOCYTIC SYNDROME - A PROB ABLY UNDERESTIMATED CAUSE OF THROMBOCYTOPENIA IN ICU PATIENTS, Annales francaises d'anesthesie et de reanimation, 14(6), 1995, pp. 514-516
PAF AND HEMATOPOIESIS .3. PRESENCE AND METABOLISM OF PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW
Authors: DENIZOT Y TRIMOREAU F DUPUIS F VERGER C PRALORAN V
Citation: Y. Denizot et al., PAF AND HEMATOPOIESIS .3. PRESENCE AND METABOLISM OF PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW, Biochimica et biophysica acta. Molecular cell research, 1265(1), 1995, pp. 55-60
ACSDKP SERUM CONCENTRATIONS VARY DURING CHEMOTHERAPY IN PATIENTS WITHACUTE MYELOID-LEUKEMIA
Authors: LIOZON E VOLKOV L COMTE L TRIMOREAU F PRADELLES P BORDESSOULE D FRINDEL E PRALORAN V
Citation: E. Liozon et al., ACSDKP SERUM CONCENTRATIONS VARY DURING CHEMOTHERAPY IN PATIENTS WITHACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 89(4), 1995, pp. 917-920
DECREASED LEVELS OF PLATELET-ACTIVATING-FACTOR IN BLOOD OF PATIENTS WITH LYMPHOID AND NONLYMPHOID HEMATOLOGIC MALIGNANCIES
Authors: DENIZOT Y DUPUIS F TRIMOREAU F PRALORAN V LIOZON E
Citation: Y. Denizot et al., DECREASED LEVELS OF PLATELET-ACTIVATING-FACTOR IN BLOOD OF PATIENTS WITH LYMPHOID AND NONLYMPHOID HEMATOLOGIC MALIGNANCIES, Blood, 85(10), 1995, pp. 2992-2993
A NEW APPROACH OF ACUTE LYMPHOBLASTIC-LEUKEMIA IMMUNOPHENOTYPIC CLASSIFICATION - 1984-1994 THE GEIL EXPERIENCE
Authors: GARAND R BENE MC GARDAIS J DUBOSCMARCHENAY N LACOMBE F LEGLISE MC LECALVEZ G BERNIER M MASSY M GRIVEAU AM BROUTARD P LEBRUN C BONHOMME J CHASSAGNE B DEMEOCQ F RAPATEL C TAVERNIER F JOUAULT H LELONG F SOLARY E CASASNOVAS RO MAYNADIE M BENSA JC FAVRE M JACOB MC SARTIAUX C HUART JL DROUET M PRALORAN V TRIMOREAU F CAMPOS L LARESE A PONCELET P BESSONFAURE I BRUNET C LAVABREBERTRAND TL TAIB J KANDEL G JUNG G HARROUSSEAU JL PHILIP P MONPOUX F BAUDOUIN F SUDAKA I CALDANI C POMIER G BERNARD A REGUER M SCHILL H BOURIN P ARBORIO M SCHAISON G BOUMSELL L ADAM M DOUAI L VANHAECKE D BRIZARD A ROUALET JP TABARY T CHAUMAREL I GENETET N FAUCHET R DRENOU B LEES O LENORMAND B VANNIER JP LEPETIT JC ACQUART S SABIDO O GUYOTAT D VASSELON C FALKENRODT A ALBERT A BREMOND JL GEORGET MT ROUBINET F KUHLEIN E LEBARON F DUTHILLEUL P REUMAUX F FAURE G KOLOPPSARDA MN BORDIGONI P WITZ F BAYLE C ANTONINI J CHARPENTIER A
Citation: R. Garand et al., A NEW APPROACH OF ACUTE LYMPHOBLASTIC-LEUKEMIA IMMUNOPHENOTYPIC CLASSIFICATION - 1984-1994 THE GEIL EXPERIENCE, Leukemia & lymphoma, 13, 1994, pp. 1-5
VARIATIONS OF SERUM ACSDKP CONCENTRATIONS DURING INDUCTION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: LIOZON E VOLKOV L COMTE L TRIMOREAU F PRADELLES P BORDESSOULE D FRINDEL E PRALORAN V
Citation: E. Liozon et al., VARIATIONS OF SERUM ACSDKP CONCENTRATIONS DURING INDUCTION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000305-10000305
Risultati: 1-25 |